Beijing Fino Weikang Biotechnology Co., Ltd.

Finowicam

Leading the technological innovation of space omics
Empowering precision medicine

Finowicam

One-stop solution for space biology

Finowicam

Every cell is not an island.

Solution

Focus on creating a one-stop space biology solution for multi-application scenarios

Basic scientific research

Disease pathogenesis and discovery of biological targets
MORE
Clinical application

Clinical efficacy evaluation and molecular classification diagnosis of diseases
MORE
Drug Development

Screening and identification of new targets, research and development of drug resistance mechanisms
MORE

Technical Services

The company has introduced technology and platform, combined with independent research and development, has established a complete multi-group (DNA\RNA \protein) detection platform.

Spatial Multi-omics Technical Service

It has a space multi-omics platform, which integrates research and development, laboratory services and clinical application development, and provides a one-stop space biology solution for domestic multi-omics (DNA\RNA \protein).

Tissue RNA in situ detection

RNAscope technology belongs to the new generation of RNA in situ hybridization technology, compared to the traditional RNA in situ hybridization technology has obvious advantages, the company has a skilled technical backbone of the platform, can achieve slice staining, image acquisition, results interpretation, quantitative analysis of the overall process, to obtain high-quality results.

Organoid paraffin sample preparation

With the introduction of foreign advanced micro sample preparation experience and CellGel sample processing gel, organoid samples can be fixed in a local area, and the naked eye can clearly and easily locate the area, which is convenient for subsequent paraffin sections and corresponding detection.

Histopathology Technical Service

Provide complete histopathological technical services, including FFPE wax block embedding of pathological samples, slice preparation, TMA tissue chip preparation, staining (H & E, IHC, FISH, etc.), pathological reading, data analysis, etc.

Products

About Us

Beijing Fino Weikang Biotechnology Co., Ltd.

beijing finoweikang biological technology co., ltd., headquartered in beijing, to tissue samples in situ space visualization technology as the core, focus on creating multi-application scenarios of one-stop space biology solutions. The company has pathology technology platform and medical resources, integrating research and development, laboratory services and clinical application development, aiming to realize the concept of "precision medical practitioner" and promote the development of life science research, drug research and development and clinical medicine.

Since its establishment, Finowicom has always been adhering to the core concept of "leading space omics technology innovation and enabling precision medicine", and in line with the purpose of "science, integrity and win-win", it has continuously integrated technology platforms and expanded the application of new technologies in clinical applications.

2022 Year

Established

Information Center

Relying on innovative technology platform and application development concept, it has won a number of awards in domestic innovation and entrepreneurship competition.

P4 The 7th Cancer Precision Medicine Conference of 2023 Ends Successfully

From December 7 to 8, P4 2023's 7th tumor precision medical conference was held in Crowne Plaza Beijing Chaoyang Youtang. P4 Conference is an annual professional brand event accurately positioned in the field of tumor precision. In this conference, more than 60 academicians/regulators/clinicians/scientific research authoritative experts and KOL, a precision pharmaceutical company/diagnostic company, led the attendance and conducted special speeches or round-table discussions. More than 1000 representatives of industry elites in the field of precision medicine gathered at the scene. As one of the exhibitors, Finowicom participated in it and had a rich exchange with many participants.

2023-12-11

Signing Cooperation | Collaborative Innovation and Development of Medical Workers and the Second Qilu Medical Discipline Integration and Achievement Transformation Summit Forum Held Successfully

On November 30, sponsored by the Management Committee of Jinan International Medical Center and jointly organized by Jinan Medical Development Group Co., Ltd. and Shandong University Pharmaceutical Industry Alumni Association, the "Medical Industry Collaborative Innovation and Development and the second Qilu Medicine discipline Integration and achievement Transformation Summit Forum" was successfully held in Jinan International Medical Center. More than 100 experts, scholars and industry leaders gathered together to look forward to the bright future of collaborative innovation and development of medical workers and share the gratifying achievements of Qilu medicine. Huaiyin District Party Committee Secretary, Jinan International Medical Center Party Committee Secretary Sun Changjian presided over the opening ceremony. Lei Jie, chairman of the CPPCC and commander-in-chief of the construction headquarters of Jinan International Medical Center, attended the event and delivered a speech.

2023-12-05